Concepedia

Hematologic Malignancy Cell Therapy

Hematologic Malignancy Cell Therapy is a therapeutic approach within cell-based immunotherapy that involves the administration of engineered or modified cellular agents to selectively target and eliminate malignant cells in hematologic disorders such as leukemias, lymphomas, and multiple myeloma.

418

Publications

27.9K

Citations

3.6K

Authors

915

Institutions

Publications per year

2017–2026

151

Parents

Publications

418

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin, Arnon Nagler, E Naparstek et al. · Blood · 1998 · 1.9K citations · Full text

, , +17

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin, Arnon Nagler, E Naparstek et al. · Blood · 1998 · 1.8K citations

, , +17

Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation

Jan‐Inge Henter · Blood · 2002 · 900 citations

, , +15

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy

Teru Hideshima, Dharminder Chauhan, Yoshihito Shima et al. · Blood · 2000 · 859 citations

, , +16

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy

Rebecca Gardner, David Wu, Sindhu Cherian et al. · Blood · 2016 · 749 citations · Full text

, , +14

1–5 of 418

Authors

3.6K

  1. MD
    Mark D. Minden

    Princess Margaret Cancer Centre, Canada

    9 publications · 574 citations

    9

    h-index

  2. MK
    Marina Konopleva

    The University of Texas MD Anderson Cancer Center, United States

    7 publications · 260 citations

    7

    h-index

  3. AS
    Anthony S. Stein

    City of Hope, United States

    7 publications · 344 citations

    7

    h-index

  4. AK
    Armand Keating

    Princess Margaret Cancer Centre, Canada

    6 publications · 566 citations

    6

    h-index

  5. CB
    CD Buckner

    Fred Hutch Cancer Center, United States

    6 publications · 302 citations

    6

    h-index

1–5 of 3.6K

Institutions

915

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    20 h-index

    143 publications

    6.1K citations

  2. Dana-Farber Cancer Institute

    Boston, United States

    17 h-index

    104 publications

    18.8K citations

  3. Memorial Sloan Kettering Cancer Center

    New York, United States

    14 h-index

    39 publications

    5.1K citations

  4. Fred Hutch Cancer Center

    Seattle, United States

    14 h-index

    45 publications

    4.9K citations

  5. Princess Margaret Cancer Centre

    Toronto, Canada

    12 h-index

    56 publications

    5.5K citations

  6. Inserm

    Paris, France

    12 h-index

    67 publications

    3.1K citations

  7. University of Washington

    Seattle, United States

    11 h-index

    54 publications

    7.4K citations

  8. National Institutes of Health

    Bethesda, United States

    11 h-index

    41 publications

    4.6K citations

1–8 of 915

Venues

  1. Blood

    51 publications · 8.9K citations

    31

    h-index

  2. PubMed

    Repository · 43 publications · 1.4K citations

    22

    h-index

  3. British Journal of Haematology

    BJH · 15 publications · 959 citations

    15

    h-index

  4. Leukemia

    14 publications · 1K citations

    14

    h-index

  5. Bone Marrow Transplantation

    16 publications · 766 citations

    12

    h-index

1–5